Please login to the form below
IFPMA
This page shows the latest IFPMA news and features for those working in and with pharma, biotech and healthcare.
Biopharma industry launches Berlin Declaration to ensure equal access during future pandemics
The International Federation of Pharmaceutical Manufacturers &Associations (IFPMA) will present the proposal to the G7, G20, multilateral organisations and other decision-makers involved in pandemic preparedness. ... Thomas Cueni, director general of
Latest news
-
US backs proposal to waive IP protection for COVID-19 vaccines
added. The International Federation of Pharmaceutical Manufacturers &Associations (IFPMA) also called the US’ decision “disappointing”, adding that “a waiver is the simple but the wrong answer to what is a complex
-
Pfizer acquires Amplyx Pharmaceuticals, including new potential class of therapeutics
Last year, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) joined forces with leading pharma and biotech companies to launch the AMR Action Fund.
-
Stakeholder meeting kick-starts dialogue on COVID-19 vaccine supply chain issues
The Global COVID-19 Vaccine Supply Chain &Manufacturing Summit was convened by the independent policy institute Chatham House in collaboration with COVAX, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA),
-
AMR Action Fund raises $140m from new investors to tackle antimicrobial resistance
The AMR Action Fund was launched by major pharma companies represented by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), in collaboration with the World Health Organization, the European Investment
-
Sandoz to acquire GSK’s cephalosporin antibiotic brands for up to $500m
The pharma industry has refocused on antibiotic research as of late, with the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) raising nearly $1bn to support clinical research into new antibiotics
More from news
Approximately 6 fully matching, plus 37 partially matching documents found.
Latest Intelligence
-
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
In the absence of these necessary policy reforms, a group of pharmaceutical companies, global charitable organisations and development banks, led by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), have
-
Interview: Jorge Gallardo, Almirall
He is a member of the executive board of IFPMA (International Federation of Pharmaceutical Manufacturers and Associations).
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest appointments
-
Syneos Health Communications announces senior hires to Europe-based team
She has previously led global campaigns for the World Health Organisation, The Global Fund, IFPMA, The Bill and Melinda Gates Foundation and the ABPI.
-
Henry Skinner has been appointed as the first CEO of the AMR Action Fund
It was developed by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and its member biopharmaceutical companies, in collaboration with the World Health Organization (WHO), the European Investment Bank and
-
Greg Perry joins IFPMA as assistant director general
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has appointed Greg Perry to be its new assistant director general. ... Thomas Cueni, IFPMA director general, said: “I am very pleased to have someone with such depth
-
IFPMA names new communications director
Helen Gallagher joins the association from Ferring Pharmaceuticals. IFPMA has appointed Helen Gallagher as its new communications director, a role that will see her act as a key spokesperson for the ... I look forward to working with the IFPMA team to
-
IFPMA appoints Fumie Griego as assistant director general
She will be a strong asset to help IFPMA bring thought leadership in addressing global health challenges.”. ... Griego will join IFPMA's leadership team and will also be working on strengthening the association's work on the industry’s value
More from appointments
Approximately 6 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Making a Difference - The Future of Pharma
On a global scale, pharma is one of the least-trusted industries. And this is despite the fact that pharma contributes more than £30 BN each year to the UK economy, supports almost 500, 000 jobs in the UK alone, and donated 1.4 BN treatments to the
-
Cameron Medical Communications Ltd
We specialise in: Marketing Codes of Practice, ABPI, EFPIA, IFPMA, Medical Information Systems and Services and Copyright.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Senior Medical Writer
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- Roche’s Polivy backed by FDA Advisory Committee for lymphoma therapy
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- LEO Pharma enters clinical trial partnership with ICON
- Sanofi/Regeneron’s Dupixent shows promise in atopic hand and foot dermatitis
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- UCB's bimekizumab shows continued improvement in hidradenitis suppurativa patients
- The Considered appoints Bam Zahraie as chief experience officer
- The impact of pharma congresses on HCPs – virtual and in person
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands
- A relentless commitment to neuroscience
- Putting the ovation into innovation: trends from ESMO
- Sanofi to acquire Provention Bio in deal worth $2.9bn
- Neurodiversity and healthcare communications – do we know enough and do we do enough?
PMHub
Page & Page and Partners
For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...
Latest intelligence
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
- WHY ARE PATIENT SUPPORT PROGRAMMES NOT WORKING?
- By offering patients knowledge, skills and confidence, they empower patients to be more actively involved in their health. Holistic support can help tackle adherence, mental health or anything else patients...
